跳至主要内容
临床试验/NL-OMON52034
NL-OMON52034招募中不适用

Multicenter Randomized Clinical Trial to Assess the Effect of Active versus Passive Recharge Burst Spinal Cord Stimulation on Pain Relief in Failed Back Surgery - Active vs. passibe burst in FBSS

Rijnstate Ziekenhuis0 个研究点目标入组 94 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
94

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 64(—)

入选标准

  • Subject of either gender between 18 and 65 years of age
  • Al least moderate level of catastrophizing as measured with the Pain
  • catastrophizing score (PCS) of at least 20.[23]
  • History consistent with FBSS of at least 6 months
  • Neurologic exam without marked motor deficit.
  • Low Back Pain or leg pain intensity should be 5 or higher measured with the
  • 11-box NRS 0-10
  • Meets all the inclusion criteria for the implantation of a neurostimulation
  • system as typically utilized in the study center. PM: depression is not an
  • exclusion criteria
  • Subject has been screened by a multi-disciplinary panel including a
  • psychologist and deemed suitable for implantation
  • Subject is able and willing to comply with the follow-up schedule and protocol
  • Subject is able to provide written informed consent

排除标准

  • Female subject of childbearing potential is pregnant/nursing or plans to
  • become pregnant during the course of the study
  • Escalating or changing pain condition within the past month as evidenced by
  • investigator examination
  • BMI >=35
  • Subject has had injection therapy or radiofrequency treatment for their low
  • back pain within the past 3 months
  • Subject currently has an active implantable device including ICD, pacemaker,
  • spinal cord stimulator or intrathecal drug pump
  • Subject is unable to operate the device
  • Severe disc degeneration at the affected level as evidenced by >50% disc
  • height loss on plain anteroposterior and lateral lumbar radiographs or CT/MRI.
  • Moderate to severe spinal stenosis due to osteophyte and/or ligamentous
  • overgrowth as evidenced by MRI or CT in the previous 6 months
  • Moderate to severe endplate degenerative changes at the affected levels
  • Grade 1-2 spondylolisthesis
  • Previous Neurostimulation therapy

研究者

发起方
Rijnstate Ziekenhuis

相似试验

进行中(未招募)
1 期
Clinical trial to avoid infection by SARS-CoV-2 in high-risk population. COVID-19
EUCTR2020-001530-35-ESFundación para la Investigación Biomédica del Hospital La Paz (FIBHULP)450
进行中(未招募)
1 期
ATILA Project: Aspirin Versus Tirofiban in Endovascular Treatment for PatientsWith Acute Ischemic Stroke Due to Tandem LesioAcute Ischemic StrokeMedDRA version: 22.1Level: LLTClassification code: 10055221Term: Ischemic stroke Class: 10029205MedDRA version: 20.0Level: SOCClassification code: 10047065Term: Vascular disorders Class: 12MedDRA version: 20.0Level: HLGTClassification code: 10003216Term: Arteriosclerosis stenosis vascular insufficiency and necrosis Class: 10047065MedDRA version: 22.1Level: PTClassification code: 10061256Term: Ischaemic stroke Class: 100000004852MedDRA version: 20.0Level: HLTClassification code: 10008192Term: Cerebrovascular and spinal necrosis and vascular insufficiency Class: 10047065
CTIS2023-508454-26-00Fundacion Publica Andaluza Para La Gestion De La Investigacion En Salud De Sevilla240
招募中
不适用
Prospective Randomized Multicenter Trial to Assess the Feasibility of a Structured Physical Exercise Training and Mediterranean-style Diet in Women With BRCA1/2MutationsC50C56Malignant neoplasm of breastMalignant neoplasm of ovary
DRKS00005736Klinikum rechts der Isar der TU München, Frauenklinik60
已完成
3 期
Multicenter Randomized Controlled Trial to Assess the Necessity of Second-look Endoscopy after Endoscopic Submucosal Dissection (ESD) for gastric neoplasms: the SAFE studyearly gastric cancer/gastric adenoma
JPRN-UMIN000007170Graduate School of Medicine, University of Tokyo250
进行中(未招募)
不适用
Multicentre, randomized clinical trial to evaluate safety and efficacy of Hyperthermic Intra-peritoneal Chemotherapy (HIPEC) with Mitomycin C used during surgery for treatment of locally advanced colorectal carcinomaColorectal cancer
EUCTR2015-001801-15-ESFIBICO